Issue 46, 2023

An estradiol-functionalized red-emissive photosensitizer for enhanced and precise photodynamic therapy of breast cancers

Abstract

In this work, we developed a red-absorbing photosensitizer (NBS-ER) with specific targeting ability toward estrogen receptors (ER). NBS-ER could specifically bind the overexpressed ER in breast cancers to increase its accumulation, thereby amplifying the photodynamic therapeutic effect. With the aid of red fluorescence from NBS-ER, imaging-guided therapy could be achieved.

Graphical abstract: An estradiol-functionalized red-emissive photosensitizer for enhanced and precise photodynamic therapy of breast cancers

Supplementary files

Article information

Article type
Communication
Submitted
05 Jan 2023
Accepted
15 May 2023
First published
16 May 2023

Chem. Commun., 2023,59, 7060-7063

An estradiol-functionalized red-emissive photosensitizer for enhanced and precise photodynamic therapy of breast cancers

X. Yue, T. Guo, H. Zhang, B. Wang, M. Lan and X. Song, Chem. Commun., 2023, 59, 7060 DOI: 10.1039/D3CC00063J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements